A 67-year-old male patient presented with rapid progression of whitening and loss of hair in past 2 months was consulted due to the suspicion of hypothyroidism.
Amyloidosis
was considered rare, and the incidence was reported to be 0.5% in the total autopsy cases, less than one half of these cases had been diagnosed clinically. ' Thus amyloidosis may be often unrecognized antemortem. Although loss of hair was reported in some cases ofamyloidosis by dermatologist, the incidence may be rare or unnoticed because there was no description about loss of hair in other studies containing 236 cases, and 42 cases.
Furthermore, whitening of hair has not been described in the reported cases of amyloidosis. On the other hand, cardiomegaly is common in amyloidosis.
' Here we report a case of primary amyloidosis presented with rapid progression of whitening and loss of hair 3 years after the finding of cardiomegaly. Repeated skin biopsies (scalp, leg, back) showed amyloid substance around the blood vessels and papilla ( Figure  3 , scalp). The substance was resistant to the treatment of potassium permagnate. He was diagnosed to have primary amyloidosis. DMSO treatment was started on December 5, 1985 (2.5 ml, orally two times aday, 1 ml= 78%).
About 8 months after treatment, the scalp hair and beard began to grow and turn to black gradually ( Figure  4 ). Cardiomegaly and hepatomegaly still exist after therapy however the severity seems not aggravate by symptoms, X-ray and physical examination.
COMMENTS
The diagnosis of amyloidosis depends on tissue biopsy. Although it was accepted that rectum biopsy was a safe and highly diagnostic method, there was a report showing that prostate biopsy was also a simple and good diagnostic method. In our study, prostate biopsy gave the clue to diagnosis and it was confirmed by subsequent skin biopsies.
Unless the patient had enlarged prostate with slightly elevated serum acid phosphatase, the diagnosis would have been delayed, because this relatively rare disease presented itself with such uncommon symptoms of rapid onset on whitening and loss of hair.
Since the patient had no obvious chronic inflammatory disorder and the specimen of biopsy resisted to potassium permagnate, he was considered to have primary amyloidosis.
Heart disease is very commonin primary amyloidosis, and is reported to involve 90% of the patients with primary amyloidosis.
Amyloid can invade myocardium, endocardium, valves, conduction system, pericardi-um, coronary vessels, causing congestive heart failure, valvular disease, arrhythmia and angina pectoris clinically.7' ' Hepatomegaly is also common in amyloidosis.
The patient had been found to have cardiomegaly and hepatomegaly about 3 years before the symptoms of whitening and loss of hair. Thus, it is likely that cardiomegaly and hepatomegaly appeared as manifestations of amyloidosis.
The loss and whitening of hair also probably resulted from deposition of amyloid substance as shown by the skin biopsies of the scalp. The course of primary amyloidosis is usually progressive. There were only a few controversial reports about the effect of treatment of primary amyloidosis with DMSO.9'10^In this patient, the regrowth and blackening of the hair seems to be brought about by the DMSO treatment.
The result suggests that DMSO may be effective in some of the symptoms of amyloidosis.
No adverse effect was noted during the treatment except for the unpleasant odor of the drug. 
